FR EN

Back


19/04/2017
Idinvest portfolio company DAMAE Medical raises €2m to develop its lead product for non-invasive, in-depth imaging and characterization of the skin
DAMAE Medical, a leading French medtech company, announces the closing of a €2 million investment round with Kurma Partners, Idinvest Partners, News Invest, Paris-Saclay Seed Fund co-managed by Partech Ventures, and private investors. DAMAE Medical was founded in September 2014 to revolutionize skin cancer diagnosis through its one-of-a-kind technology based on optical tomography. The company's strong ambition has already paid off: since its inception, over €1 million has been raised from Bpifrance and other sources.

Download the pdf file





X

X

X